Regulus Therapeutics: Below. A Summary Of The Principal Features Of The Amended 2019 Plan Is Set Forth Under The Heading Proposal 5 Approval Of An Amendment To The 2019 Equity Incentive Plan Contained In The Company S Definitive Proxy Statement On, Financial Statements And Exhibits

Show full article

This functionality is available for registred users only

• Full name
  Regulus Therapeutics Inc.
• Registration country
  USA
• Industry
  Pharmaceutical Preparation and Biotechnology
• М/S&P/F
  *** / *** / ***